Enanta

$42.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-0.09%) Today

$0.00 (0.00%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell Enanta and other stocks, options, and ETFs commission-free!

About ENTA

Enanta Pharmaceuticals, Inc. operates as a biotechnology company. It engages in the research and development of molecule drugs for the treatment of viral infections and liver diseases. The firm offers the medicine under the brands Mavyret and Viekira Pak. The company was founded by Peter O. Kliem and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA. The listed name for ENTA is Enanta Pharmaceuticals, Inc. Common Stock.

CEO

Jay R. Luly

Employees

141

Headquarters

Watertown, Massachusetts

Founded

1995

Market Cap

861.09M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

157.20K

High Today

$43.21

Low Today

$41.93

Open Price

$42.79

Volume

82.98K

52 Week High

$67.88

52 Week Low

$38.40

Collections

Technology

Health

Biotechnology

Research And Development

2013 IPO

North America

Analyst Ratings

63%

of 8 ratings

Buy

63%

Hold

25%

Sell

13%

ENTA Earnings

-$1.46

-$0.76

-$0.05

$0.65

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

-$0.95 per share

Actual

-$1.46 per share

Replay Earnings Call